Clinical Trial

Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Prospective single-arm clinical study of adebrelimab combined with concurrent chemoradiotherapy in locally advanced cervical cancer
Trial Details
NCT Number NCT06149767
Lead Sponsor Fujian Cancer Hospital
Conditions Cervical Cancer
Enrollment 26 participants
Start Date 2024-01
Primary Completion 2028-02 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2023-11-29